Despite extensive research into the toxicity of solvents to the central nervous system (CNS), little is known about the possible mechanisms leading to behavioural changes and impairment in performance from experimental, clinical, and epidemiological investigations.'
Apart from a few substances which cause a well defined pattern ofpathological change associated with both a peripheral neuropathy and dysfunction of the CNS,2 most organic solvents produce rather nonspecific effects, primarily affecting the CNS. Such effects range from depressed mood to loss of memory but the most consistent effect is represented by slow visuomotor performance or prolonged reaction times.3 Electrophysiological parameters are only slightly modified by industrial exposure to low levels of solvent mixtures and they show patterns similar to those of single solvents that are independent of their primary toxic effects. 4 As a whole, these findings are intriguing and challenging, since organic solvents as a group share few physical features and even fewer chemical properties.5 None of these attributes can explain the observed effects, with the exception of the affinity for the nervous system, which is due to the fact that most solvents are strongly lipophilic. It should be recognised, however, that any changes induced in membrane fluidity would also affect the peripheral nervous system, especially the myelin sheaths, thus causing more definite changes in nerve conduction velocities than those reported so far. It should also be recognised that the brain has a tissue/blood partition coefficient comparable with the remainder ofthe vessel rich group. The half life of solvents in the brain is thus not expected to be longer than in other organs. As a result, the selective vulnerability of some CNS functions is not accounted for by toxicokinetic factors, although an accumulation within lipoid subcellular structures such as plasma membranes cannot be excluded. Biological half times of lipophilic solvents in such components might be longer than those expected for the whole brain.5
It seems that at present there is no common thread to account for all observed effects that solvents have on the nervous system. Indeed, there is no reason to think that there will be one in view of the considerable structural differences in the various solvents at present used in industry. 2 This view is supported by the fact that similar compounds do not share metabolic pathways and, as a consequence, do not have common mechanisms of toxicity.6 Furthermore some substances-for example, carbon disulphide-may produce distinct syndromes by acting through different mechanisms on multiple targets. 2 Recently, it has been shown that subacute exposure to styrene causes striatal and tuberoinfundibular dopamine depletion in rabbits.' This mechanism is common to other monocyclic hydrocarbons biotransformed into metabolites having an alpha-keto acid as the lateral chain. 6 The effects on brain dopamine are predictable on the basis of the chemical structure of metabolites rather than of the parent compounds. Since dopamine condenses non-enzymatically with many solvent metabolites having a reactive carbonylic group in their molecule (A Mutti et al, unpublished data), this mechanism may explain why apparently different solvents produce similar effects.
A list of the solvent metabolites that condense with dopamine in vitro to form tetrahydroisoquinolines is shown in the Little is known about the possible effects of tetrahydroisoquinolines but they probably have both pharmacological and toxic properties. For instance, salsolinol and carboxysalsolinol, which are tetrahydroisoquinolines formed by the condensation of dopamine with acetaldehyde and pyruvic acid, respectively, seem to be responsible for behavioural changes in alcoholics. '7 Since it is now accepted that occupational exposure to organic solvents may induce some behavioural disturbances, which in turn may arise from a range of different mechanisms, it seems justified to focus attention on more specific neuroendocrine effects. The advantage of such an approach relates to the specificity of the neurochemical mechanisms controlling pituitary secretion. Although these mechanisms may also be affected by confounding or modifying factors, several extraneous variables such as educational and cultural background may be ruled out. This allows for the exploration of causal rather than multifactorial relations between solvent exposure and CNS dysfunction. Furthermore, such an approach may be valuable for the study ofother effects ofsolvent exposure, such as those on sexual behaviour and reproductive toxicity. The evidence now strongly suggests that the major pathways that are affected in the hypothalamic control of gonadotropins in primates are adrenergic and dopaminergic.'" Although neuroactive drugs are known to induce only transient effects on the CNS pathways necessary for normal gonadotropin secretion, occupational exposure to neurotoxins may cause repeated reversible effects, which are difficult to distinguish from'chronic effects because ofthe chronic nature ofexposure. After even short term exposures, a complete recovery of neuroendocrine changes would require several weeks."' Questions remaining to be answered include the role of a possible tolerance, which is known to develop, for instance, during chronic alcohol abuse.'" In this case, however, a complicated pattern may result from liver damage and liver dysfunction.'920 In workers occupationally exposed to styrene, there is evidence of a relation between recent exposure and measurable effects on the CNS.'3 14152122 As a result, at least in this occupational setting, the fact that prolonged exposure induces tolerance may be ruled out. An even more important question is the importance of such effects with regard to the long term prognosis of workers exposed to 
